The Nathan Shock Aging Center will build upon the recognized strengths in basic research in aging at San Antonio, e.g.: (1) the utilization of transgenic animals and dietary restriction to study of the mechanism(s) of aging at the molecular, cellular, and physiological levels, (2) the detailed characterization of survival and pathological lesions in aging rodents to determine the effect of aging, disease, and their interaction on biological processes, and (3) the large number of faculty at San Antonio who are actively involved in basic biological research in aging. The Center proposed in this application will consist of three Resource Cores, a Research Development Core, and a Program Enrichment Core. The Resource Cores will include a Transgenic Core, an Animal Core, and a Pathology Core. The central premise underlying the Nathan Shock Aging Center described in this proposal is that identifying the biological mechanisms leading to senescence can best be achieved by manipulating the whole organism genetically, nutritionally, or pharmacologically in ways that modify the aging process rather than by relying on phenomenological studies of the aging phenotype. The purpose of the Nathan Shock Aging Center is to combine this approach with our existing research strengths to enhance basic research on aging in five ways. First, the Center will facilitate genetic manipulations of animal models to test hypotheses relevant to senescence; services required to produce transgenic mice, transgenic rats, and transgenic mice with gene knockouts will ter investigators. Second, the Center will provide the resources and environment for the development of new genetic, nutritional, and pharmacological interventions in rodent models that are designed to modify the aging process(es). Animals from these interventions will then be supplied to Center investigators to test hypotheses concerning the mechanism(s) of mammalian aging. Third, the center will characterize the pathological status of all animal models developed in the Center. Fourth, the Center will promote novel approaches to the study of aging by providing funds for pilot projects. Fifth, the Center will have an administrative base designed to enhance collaborative research on aging.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
1P30AG013319-01
Application #
2055284
Study Section
Special Emphasis Panel (ZAG1-CAG-1 (30))
Project Start
1995-07-10
Project End
2000-06-30
Budget Start
1995-07-10
Budget End
1996-06-30
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Kraig, Ellen; Linehan, Leslie A; Liang, Hanyu et al. (2018) A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects. Exp Gerontol 105:53-69
Ungvari, Zoltan; Tarantini, Stefano; Donato, Anthony J et al. (2018) Mechanisms of Vascular Aging. Circ Res 123:849-867
Weiss, Roxanne; Fernandez, Elizabeth; Liu, Yuhong et al. (2018) Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice. Aging (Albany NY) :
Qin, Kunhua; Zhang, Ning; Zhang, Zhao et al. (2018) SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice. Diabetologia 61:906-918
Salmon, Adam B; Dorigatti, Jonathan; Huber, Hillary F et al. (2018) Maternal nutrient restriction in baboon programs later-life cellular growth and respiration of cultured skin fibroblasts: a potential model for the study of aging-programming interactions. Geroscience 40:269-278
Gelfond, Jonathan; Goros, Martin; Hernandez, Brian et al. (2018) A System for an Accountable Data Analysis Process in R. R J 10:6-21
Sills, Aubrey M; Artavia, Joselyn M; DeRosa, Brian D et al. (2018) Long-term treatment with the mTOR inhibitor rapamycin has minor effect on clinical laboratory markers in middle-aged marmosets. Am J Primatol :e22927
Xu, Ming; Pirtskhalava, Tamar; Farr, Joshua N et al. (2018) Senolytics improve physical function and increase lifespan in old age. Nat Med 24:1246-1256
Unnikrishnan, Archana; Hadad, Niran; Masser, Dustin R et al. (2018) Revisiting the genomic hypomethylation hypothesis of aging. Ann N Y Acad Sci 1418:69-79
Van Skike, Candice E; Jahrling, Jordan B; Olson, Angela B et al. (2018) Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol 314:H693-H703

Showing the most recent 10 out of 231 publications